Welcome to our dedicated page for Atlas Lithium SEC filings (Ticker: ATLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atlas Lithium Corporation filings document the regulatory record for a Nevada lithium development company advancing the Neves Project in Brazil. Proxy materials cover annual meeting procedures, shareholder voting matters and board governance, while 8-K reports disclose director changes and other material corporate events.
Capital markets filings and related 8-K exhibits address the company's common stock, shelf registration statement, at-the-market offering program and prospectus supplements. Periodic reports referenced by the company provide risk-factor disclosure for Atlas Lithium and its subsidiaries, including project-development and critical-minerals operations.
Atlas Lithium Corp CEO Marc Fogassa reported a disposition to the issuer of 27,272 shares of common stock at $4.487 per share on February 12, 2026. The transaction was effected by Goldman Sachs & Co. LLC under a previously established Rule 10b5-1 trading plan.
Following this transaction, Fogassa directly beneficially owned 4,871,104 shares of Atlas Lithium common stock and indirectly beneficially owned an additional 105,608 shares through entities he controls.
Atlas Lithium Corp VP of Corporate Strategy Igor Tkachenko received a stock grant. On 01/31/2026, he acquired 6,604 shares of common stock at $0.00 per share as an award, increasing his directly held stake to 275,501 shares.
Atlas Lithium Corp's chief executive officer, director, and 10% owner Marc Fogassa reported a planned sale of common stock. On February 5, 2026, 27,272 shares of Atlas Lithium common stock were disposed of at an average price of $4.5197 per share under a previously established Rule 10b5-1 trading plan executed by Goldman Sachs & Co. LLC.
Following this transaction, Fogassa beneficially owns 4,898,376 shares of Atlas Lithium common stock directly, plus an additional 105,608 shares held indirectly through entities he controls. The filing confirms he remains both a senior executive and a significant shareholder in the company.
Atlas Lithium Corp VP of Corporate Strategy Igor Tkachenko reported acquiring 7,543 shares of common stock on January 12, 2026. The shares were reported at a price of $0.00 per share, indicating a no-cost stock award or similar equity grant as disclosed in the filing. Following this transaction, Tkachenko beneficially owns 268,897 shares of Atlas Lithium common stock in direct ownership.
Atlas Lithium Corp insider Marc Fogassa, who is a director, Chief Executive Officer and more than 10% owner, reported a planned sale of common stock. On January 13, 2026, 27,272 shares of Atlas Lithium common stock were disposed of at a price of $5.6262 per share, in a transaction effected by Goldman Sachs & Co. LLC under a previously established Rule 10b5-1 trading plan. After this transaction, Fogassa reported owning 4,925,648 shares of common stock directly and an additional 105,608 shares indirectly through entities he controls.
Atlas Lithium Corp insider Marc Fogassa, the company’s CEO, director and a 10% owner, reported a sale of common stock. On 12/12/2025, 27,272 shares were disposed of at an average price of $4.3543 per share, coded as a disposition. The transaction was carried out by Goldman Sachs & Co. LLC under a previously established Rule 10b5-1 trading plan, indicating it followed pre-set instructions rather than a discretionary trade.
Following this sale, Fogassa beneficially owns 4,552,924 Atlas Lithium shares directly and an additional 105,608 shares indirectly through entities he controls. The filing is made by a single reporting person.
Atlas Lithium Corporation may sell additional shares of its common stock with an aggregate offering price of up to $40,000,000 under its at-the-market program. The company entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC as sales agent, allowing Atlas Lithium, at its sole discretion, to issue and sell common stock from time to time.
To support these potential sales, Atlas Lithium filed a prospectus supplement with the SEC under its existing shelf registration statement on Form S-3, which became effective on September 3, 2025. A legal opinion from Brownstein Hyatt Farber Schreck, LLP regarding the validity of these shares under Nevada law is included as Exhibit 5.1. The company notes that this report itself does not constitute an offer to sell or a solicitation to buy the securities.
Atlas Lithium Corporation is establishing an at-the-market program to sell up to $40,000,000 of common stock through H.C. Wainwright & Co. as sales agent. Sales will be made from time to time on Nasdaq under the symbol ATLX, with Wainwright earning up to a 3.0% commission on gross proceeds.
As of December 8, 2025, the company had 26,554,331 shares of common stock outstanding and illustrates a scenario of selling about 8,988,764 additional shares at $4.45 per share to raise $40,000,000. On this basis, pro forma net tangible book value would rise from $2.06 to $2.63 per share, implying $1.82 per-share dilution for new investors. Net proceeds are intended for general corporate purposes, including development and commercialization of its Brazilian lithium concentrate project, working capital, capital expenditures and general and administrative expenses.
Atlas Lithium Corp (ATLX) reports an insider stock sale by its Chief Executive Officer, Marc Fogassa, who is also a director and 10% owner. On 11/13/2025, 27,272 shares of common stock were disposed of at a price of $4.4518 per share. After this transaction, the reporting person beneficially owns 4,607,468 shares directly and 105,608 shares indirectly through entities he controls. The sale was executed by Goldman Sachs & Co. LLC under a previously established Rule 10b5-1 trading plan.
Atlas Lithium Corporation (ATLX) filed its Q3 2025 report, highlighting continued project development and financing progress. The company reported a net loss attributable to stockholders of $6,953,276 for the quarter and $21,529,466 for the nine months. Basic and diluted loss per share was $0.35 for the quarter and $1.18 year-to-date.
Cash and cash equivalents were $20,977,191, up from $15,537,476 at year-end, with total assets of $72,169,028. Operating cash outflows were $15,365,255 for the nine months, offset by $28,687,888 of financing inflows, primarily from at-the-market (ATM) equity sales. During Q3 2025, the company sold 2,916,366 common shares under its ATM programs, generating aggregate net proceeds of approximately $15.1 million. Property and equipment reached $46,949,039 as the Neves Lithium Project advanced: the project received a mining concession on May 27, 2025, completed a Definitive Feasibility Study on August 4, 2025, and has a fully paid dense media separation plant in Brazil, with the DFS citing an expected lithium recovery rate of 61.7% and estimated capital expenditures of $57.6 million. Convertible debt stood at $10,131,347. As of November 10, 2025, there were 23,570,445 common shares outstanding.